Related Experiment Video
Updated: Aug 14, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Tumour necrosis factor-alpha depletes histone deacetylase 1 protein through IKK2
Y N Vashisht Gopal1, Tarandeep S Arora, Michael W Van Dyke
1Department of Molecular and Cellular Oncology, Unit 079, UT M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.
Abstract:
Class I histone deacetylases (HDACs) are ubiquitous enzymes that repress gene expression by deacetylating histone tails and promoting chromatin compaction. Pro-inflammatory agents activate programmes of gene expression through transcription factors such as nuclear factor-kappaB (NF-kappaB), even in the context of ubiquitous HDAC activity. How this is accomplished remains unknown. We found that cells treated with the pro-inflammatory cytokine tumour necrosis factor-alpha rapidly and substantially reduced HDAC1 protein levels without affecting other class I HDACs. In addition, HDAC1 depletion occurred through protein degradation, required IKK2 activity and resulted in increased transcription from both NF-kappaB-associated and unassociated gene promoters. Our study suggests that the activation of programmes of gene expression by pro-inflammatory agents requires global changes in specific critical epigenetic regulators such as HDAC1.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
The Extrinsic Apoptotic Pathway

